The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and Wednesday and not separately reported by Alliance News:
----------
Hutchmed (China) Ltd - Hong Kong-based treatments of cancer and immunological diseases - Chief Financial Officer Johnny Cheng sells 1.3 million shares at average HK$27.07, worth HK$35.2 million, about £3.8 million, on Friday and Monday in Hong Kong. The sale represented about half of his total holding. Hutchmed reported 2022 results on Tuesday last week.
----------
Man Group PLC - London-based hedge fund manager - President Robyn Grew sells 156,717 shares at 287.77 pence, worth £450,992, on Tuesday.
----------
RIT Capital Partners PLC - invests across various asset classes, industries and currencies - Director Philippe Costeletos buys 20,860 shares via Nisaki Family Trust at 2,005p, worth £418,243, on Tuesday. RIT Capital Partners reported 2022 results last week.
----------
Haleon PLC - Weybridge, Surrey-based consumer healthcare products - Chair Dave Lewis buys 31,476 shares at £3.18, worth £99,999, on Friday last week. Non-Executive Director Marie-Anne Aymerich buys 19,550 shares, also at £3.18 and also on Friday. Haleon reported annual results on Thursday last week.
----------
Copyright 2023 Alliance News Ltd. All Rights Reserved.
